HOME
ABOUT
LOG-IN
SEARCH BY
Search Results
Search Terms:Company Category= Life Sciences Company| Acureon Pharmaceuticals 1055 Westlakes Drive Suite 300 Berwyn, PA 19312 610-727-3891 Matthew Gantz mgantz@acureonpharma.com www.acureonpharma.com Acureon is focused on building a specialty pharmaceutical company in the anti-infective and hospital products areas through acquiring undervalued pharmaceutical products and in-licensing promising products in late-clinical development. Acureon is privately held and funded by three highly regarded venture firms:, Alta Partners, Domain Associates, and NEA. |
| Adesis, Inc. 27 McCullough Drive New Castle, DE 19720 302-323-4880 Susan Baylis-Powell sbaylis-powell@adesisinc.com www.adesisinc.com Adesis is a contract research organization (CRO) supporting the pharmaceutical and biopharmaceutical industry. This industry is adopting the philosophy of outsourcing reference standards (competitor’s drugs), targets, scaffolds, building blocks and advanced intermediates. Outsourcing allows medicinal chemists to focus on design and assembly of new targets for pharmacological evaluation and streamlines the early stage drug discovery process. |
| Adolor Corporation 700 Pennsylvania Drive Exton, PA 19341 484-595-1500 Lizanne Wentz questions@adolor.com www.adolor.com Adolor Corporation (Nasdaq: ADLR) is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. By applying its knowledge and expertise in pain management, along with ingenuity, Adolor is seeking to make a positive difference for patients, caregivers and the medical community. |
| Advanced Pharmaceutical Nanotech, LLC 91 Lukens Drive Suite E New Castle , DE 19720 302-655-6620 Lei-Shu Wu LSCWU@aol.com www.nanobiopharma.com We utilize Nano technology and cGMP pharmaceutical facilities to manufacture highly bioavailabe and less toxic iron supplements, tasty nano vitamin products, tasty and effective instant bones and joints care products, highly efficacious antacids, nano anti-aging skin care products, and natural antibacteria personal hygiene products. |
| AMICI, Inc. 518 Vincent St Spring City, PA 19475 610-948-7100 Michael Bono, Pres. mbono@amici-inc.com www.amici-inc.com AMICI, Inc. is a specialty Lung Administration Medical Device manufacturing company. It develops unique devices that generate sub-micronic aerosols for deep lung delivery utilizing the multi-patented Swirler ® technologies. The company also manufactures a full range of adaptors and accessories for virtually any alveolar drug delivery requirement. |
| ANP Technologies, Inc. 824 Interchange Boulevard Newark, DE 19711 302-283-1730 Theresa Simonson info@anptinc.com www.anptinc.com ANP Technologies is a nano-biotechnology company focused on the detection/diagnostics market. We market bio-hazards detection products to the first-responder market. In the near future we will roll out products to address women's health issues (pregnancy and ovulation) and infectious diseases. We also have demonstrated superiority in sensitivity on drugs-of-abuse testing and will seek regulatory approvals to market products in this field. |
| Aptagen, LLC 250 North Main Street Jacobus, PA 17407 717-278-2436 G. Thomas Caltagirone, Ph.D. mailbox@aptagen.com www.aptagen.com Aptagen, LLC is a biotechnology company offering aptamer and aptabody custom-based services to replace antibodies in research, diagnostic platforms, drug discovery and therapeutics. |
| Aquitic Technology, Inc. 34 Dora Drive Media, PA 19063 610-566-8474 George T Sikorski, Director and Corporate Secretary georgesikorski@hotmail.com Aquitic Technology, Inc has developed and patented an innovative, energy-efficient water purification and heating system, capable of producing injectible-grade water. The system can also produce small batch pure water in pharmaceutical testing and manufacture. The firm is currently licensing the process in specific applications. |
| Athena Biotechnologies, Inc. Stine-Haskell Research Center 1090 Elkton Road Newark, DE 19711 302-224-3450 Barry L. Marrs, CTO bmarrs@athenabio.com www.athenabio.com Athena Biotechnologies, Inc. is a privately-held, early-stage biotechnology company. AthenaBio is focused on harvesting bioactive molecules from nature. We are committed to delivering these novel chemicals and enzymes to fill critical unmet needs in pharmaceuticals, agrichemicals, and industrial and therapeutic enzymes markets. |
| Augmenta Biologicals, LLC 1000 N. West St., Suite 1200 Wilmington, DE 19801 302-764-2043 Paul Simon simonpm@augmentabio.com www.augmentabio.com Augmenta is developing an enabling technology to increase the potency of immunogens used to immunize animals for antibody production and also for use in veterinary and human vaccines, without the use of conventional immune adjuvants. |
| Auxilium Pharmaceuticals 40 Valley Stream Parkway Malvern, PA 19355 484-321-5900 MaryLou McGurk mlmcgurk@auxilium.com www.auxilium.com Auxilium Pharmaceuticals (NASDAQ: AUXL) was founded in 1999 to develop and market pharmaceutical products that focus on urology and sexual health. While we remain dedicated to this founding principle, Auxilium’s mission has expanded to include the development and marketing of novel treatment options for many of society’s unmet medical needs. |
| Avid Radiopharmaceuticals 3624 Market Street 5th Floor Philadelphia, PA 19104 215-966-6208 Nan Kruzik kruzik@avidrp.com www.avidrp.com Avid Radiopharmaceuticals is a product-focused molecular imaging company. Avid has developed proprietary radiopharmaceuticals to image amyloid plaques and is testing these agents in clinical trials for the detection of Alzheimer’s. Avid is also developing novel agents to image pathology in other types of dementia and Parkinson’s. These agents have the potential to revolutionize early diagnosis and monitoring of neurodegenerative diseases. |
| B-Tech Consulting, Ltd. 3701 Market Street 5th Floor Suite 119 Philadelphia, PA 19104 215-989-4880 Brian Moldover, Ph.D. brian@b-techconsulting.com www.b-techconsulting.com B-Tech Consulting, Ltd. provides Bio and Chemo Informatics contract research and analytical services to the Biotechnology and Pharmaceutical sectors. B-Tech Consulting, Ltd. Also provides Genomic data analysis, chemical library virtual screening, Next-Generation sequencing, expression profiling, SNP's, miRNA. |
| B. McLaughlin Associates, Inc. 1540 McDaniel Drive West Chester, PA 19380 610-430-1847 Kristen Molina Kristen@bmclaughlin.com http://www.bmclaughlin.com/ BMA is a niche provider of clinical research services based in West Chester, Pennsylvania and Phoenix, Arizona. Our services focus on Study Management, Regulatory and Financial Document Retrieval, Clinical Study Agreement/Per Patient Budget Negotiation, Informed Consent Review and Approval, Data Discrepancy Retrieval, and Regulatory Document Audits. |
| Beijing Med-Pharm Corp. 600 West Germantown Pike Suite 400 Plymouth Meeting, PA 19462 610-940-1675 F. Powell, CFO bd@beijingmedpharm.com www.beijingmedpharm.com BMP (a US public company) is a pharmaceutical marketing and distribution company in China that offers pre-market entry analysis, clinical trial management, product registration, market research, pharmaceutical distribution to hospitals, and pharmaceutical marketing to physicians, hospitals, and other healthcare providers. |
| Bioconnect Systems, Inc. 124 S. Maple Street Suite 220 Ambler, PA 19002 610-517-5737 Adam Dakin, CEO adakin@bioconnectsystems.com www.bioconnectsystems.com Development of medical technology that improves access in dialysis patients. |
| BioLeap, LLC 346A Lurgan Road New Hope, PA 18938-9252 215-371-2874 Gerry Evans information@bioleap.com www.bioleap.com Bioleap is a virtual drug discovery company focused on targets where opportunities exist to significantly improve drug performance with novel, SECOND GENERATION compounds. Development collaborations span a broad spectrum of target proteins including kinases, nuclear hormone receptors, metalloenzymes, and metalloproteases. The current focus of our internal programs is anti-bacterials. Novel compounds have been identified for peptide deformylase inhibitors. |
| Biomol International, LP 5120 Butler Pike Plymouth Meeting, PA 19462 800-942-0430 Jane Love marketing@biomol.com www.biomol.com BIOMOL, located in Plymouth Meeting, offers a wide range of biochemicals with applications in signal transduction, gene regulation, apoptosis, neuroscience, and drug discovery. In addition to purified enzymes, antibodies, and assay kits, BIOMOL’s innovative products include Nupherin-neuron transfection reagent, Fluor de Lys HDAC assay kit, and Screen-Well compound libraries. |
| BioPegasus, LLC 74 Pine Glen Road Langhorne, PA 19047 215-860-5088 Tianlin Ma info@biopegasus.com www.biopegasus.com BioPegasus, LLC provides technical services and support in the areas of molecular biology, protein biochemistry, and cell biology to local researchers both in industry and academia. |
| Biosome, Inc. 701-4 Cornell Business Park Wilmington, DE 19801 302-654-4492 Charles F. Saller, Ph.D. csaller@absbio.com www.biosome.com Biosome, Inc. is founded upon an innovative fluorescent nanoparticle detection technology with applications in drug discovery and pathogen detection. Drug discovery products will predict if potential drugs will reach their target, while greatly reducing the costs of these evaluations and vastly increasing their throughput. Pathogen detection products are being developed for markets such as food and water safety and biodefense. |
| Bristol-Myers Squibb Company Rt. 206 & Province Line Road Princeton, NJ 08540 609-252-4000 N/A web.mail@bms.com www.bms.com Bristol-Myers Squibb Company is a global pharmaceutical and related health care products company operating in three major segments: Pharmaceuticals, Nutritionals and Other Health Care. The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business. The Nutritionals segment consists of Mead Johnson Nutritionals and the Other Health Care segment consists of ConvaTec and Medical Imaging. |
| BTG Five Tower Bridge, Suite 800 300 Barr Harbor Drive West Conshohocken, PA 19428-2998 610-278-1660 Thomas Reilly, PhD info@btgplc.com www.btgplc.com BTG in-licenses, develops and commercializes pharmaceuticals and other medical technologies. With a substantial and growing revenue stream of royalties and milestone payments from out-licensed products, BTG continues to strengthen its pipeline of preclinical and clinical development programs. BTG is active in oncology, diseases of ageing, neuroscience, drug repositioning, and medical technologies. |
| Burlington County College Science Incubator 900 Briggs Road Mount Laurel, NJ 08054 856-222-9311 ext. 2801 Paula Fett pfett@bcc.edu www.bbb.edu Burlington County College Science Incubator-5 wet labs each with fume hood, lab sink, casework, and private office. |
| Capital Biosciences, Inc. 9700 Great Seneca Hwy Suite 247 Rockville, MD 20850 240-207-2314 Gary Veytsman techsupport@capitalbiosciences.com http://www.capitalbiosciences.com Capital Biosciences, Inc. offers innovative tools and solutions for life sciences researchers worldwide, including: fresh viable, frozen, and FFPE human tissues; cell immortalization products and services; and fluorescent in vivo imaging products. |
| Cartesian Software 535 Cedar Drive Lafayette Hill, PA 19444 610-940-4711 Thomas Rossi thom.rossi@cartesiansoftware.com www.cartesiansoftware.com Cartesian Software was founded to improve drug safety. The company’s product, Data Lens, helps users quickly identify safety questions and use clinical trial data more efficiently. |
| Cellular GenetiX 1600 Arch Street Suite 1211 Philadelphia, PA 19103 215-665-1193 Dr. David Targan David@cellulargenetix.com www.cellulargenetix.com Cellular GenetiX is a leading service industry provider offering various genetic and pharmacogenomic testing and functioning as a portal for patients to have access to entities involved in the highly anticipated growth sector of genomic therapies. |
| Cephalon, Inc. 41 Moores Road Frazer, PA 19355 610-344-0200 Fritz Bittenbender corporatecommunications@cephalon.com www.cephalon.com Founded in 1987, Cephalon, Inc. (headquartered in Frazer, Pennsylvania) is an international biopharmaceutical company dedicated to the discovery, development and marketing of innovative products in four core therapeutic areas: central nervous system, inflammatory disease, pain, and oncology. The company currently employs approximately 3,000 people in the United States and Europe. For more information, please visit us online: www.cephalon.com. |
| Ception Therapeutics, Inc. 101 Lindenwood Drive Suite 400 Malvern, PA 19355 610-640-2940 Janet Rivello contactus@ceptiontx.com www.ceptiontx.com Ception Therapeutics is an emerging biopharmaceutical company focused on the discovery and development of novel products to address unmet medical needs. Ception was founded by experienced pharmaceutical executives in order to develop and commercialize therapeutics in areas of significant unmet medical need. |
| Cerionx, Inc. 930 East Lancaster Pike Suite 200 Exton, PA 19341 610-363-9800 Tia Smallwood info@cerionx.com www.cerionx.com Cerionx provides biopharma drug discovery laboratories with a breakthrough approach to cleaning and sterilizing automated pipet tips used in assay development and screening. The patented TipCharger™ System uses cold plasma to reduce sample-to-sample carryover, eliminate bacterial contamination, enable the re-use of plastic tips, and deliver measurable time and cost savings, simplified process, and reduced hazardous disposal. |
| Children's Hospital of Philadelphia Abramson Research Building 34th St. and Civic Center Blvd. Philadelphia, PA 19104 215-590-5645 Greg Baker bakerg@email.chop.edu http://stokes.chop.edu/ The Children's Hospital of Philadelphia has a very diverse research effort, with expertise and novel technologies in many areas such as oncology, metabolic diseases, neurology, medical devices, and hemotology. Many breakthroughs in these areas represent potential therapeutic candidates and/or ideal platforms for start-up ventures. |
| Chiral Technologies, Inc. 800 North Five Points Road West Chester, PA 19380 800-6-CHIRAL Lorraine Evangelista chiral@chiraltech.com www.chiraltech.com Chiral Technologies,Inc., offers a full range of chiral chromatography products and services for chiral separations including HPLC and SFC columns for analytical, semi-preparative and preparative resolutions. Our products also include bulk chiral stationary phases. These CSPs are produced under cGMP conditions for the production of chiral intermediates and APIs of single enantiomer drugs for use in clinical trials or commercial scale manufacturing. |
| Cira Discovery Sciences, Inc. 3701 Market Street Suite 340 Philadelphia, PA 19104-5505 215-966-6131 Wade Rogers, President & CEO info@ciradiscovery.com www.ciradiscovery.com Cira discovers and develops biomarkers for medical diagnostics and drug discovery/development. The company develops and applies novel computational tools in high-dimensional biology primarily for the purpose of discovering multiplex markers, which are believed to be more informative than individual markers. The company validates its computational tools by targeted fee-for-service applications. Clients include universities, government, and industry. |
| CSL Behring 1020 First Avenue King of Prussia, PA 19406 610-878-4000 Roger Bentley info@cslbehring.com www.cslbehring.com CSL Behring is a global leader in the plasma protein biotherapeutics industry, dedicated to treating rare and serious diseases and passionate about improving the quality of life of patients throughout the world. |
| Cytokine PharmaSciences, Inc. Walnut Hill Plaza 150 South Warner Road, Suite 420 King of Prussia, PA 19406 610-687-1776 Dennis Willson, President & CEO dwillson@cytokinepharmasciences.com www.cytokinepharmasciences.com Cytokine PharmaSciences (CPSI) is a pharmaceutical development company focused on women's health. CPSI licenses in technologies from academia and other sources, develops products from those technologies, and outlicenses them to third parties for marketing. The company has one approved product and three in various stages of clinical development, all using its unique, controlled-release, polymer drug-delivery system. |
| Delmont Laboratories, Inc. 715 Harvard Ave PO Box 269 Swarthmore, PA 19081 800-562-5541 David J. Ganfield, PhD splvet@delmont.com www.delmont.com Delmont Laboratories, Inc. manufacturers and distributes Staphylococcal-derived products used in the treatment and prevention of recurrent human and animal staphylococcal infections. Currently, Delmont manufactures and distributes Staphage Lysate (SPL), an immunomodulator licensed for the treatment of recurrent canine pyoderma. |
| Delta Scientific, Inc. 1979 Stout Drive Building 5 Ivyland, PA 18974 215-443-5166 Janet Collem jcollem@deltasci.com www.deltasci.com Delta Scientific provides general lab equipment, reagents and supplies. Delta carries a full line of diagnostic analyzers and instruments. |
| Derma Sciences Inc. 214 Carnegie Center Suite 300 Princeton, NJ 08540 609-514-4744 Barry Wolfenson bwolfenson@dermasciences.com www.dermasciences.com Derma Sciences is a global manufacturer and marketer of advanced wound-care products. Its key product, MEDIHONEY™, is sold throughout the world. Derma has two products in development: the BIOGUARD™ line of barrier gauze dressings is pending its initial FDA marketing clearance; and DSC127, the company's novel angiotensin analog for accelerated wound healing and scar reduction is entering into a Phase II study. |
| DermAvance Pharmaceuticals 1055 Westlakes Drive 3rd Floor Berwyn, PA 19312 610-727-3935 Michelle Antonelli maa@dermavance.com www.dermavance.com DermAvance provides your practice with innovation, technology and exclusivity! We have recently launched several unique products to plastic surgeons and dermatologists for in-office dispensing only. Vivelif Cream, Serum and Mask (acetyl hexapeptide-3) provides a “Botox-booster” effect. Hyalogy, the first and only topical hyaluronic acid in nanotechnology, penetrates to the dermis for deep hydration. |
| Diasome Pharmaceuticals, LLC 625 Ridge Pike Building E, Suite 402 Conshohocken, PA 19428 609-923-9443 lrosenberg@diasome.com lrosenberg@diasome.com www.diasome.com Diasome Pharmaceuticals is dedicated to improving the lives of Type 1 and Type 2 Diabetes patients. Our patented nanotechnology targeted delivery systems have demonstrated preferential delivery of insulin to the liver. We have developed a proven process for advancing compounds from early stage through completion of Phase II studies faster than traditional methods at a fraction of the cost. |
| Discovery Laboratories, Inc. 2600 Kelly Road Suite 100 Warrington, PA 18976 215-488-9300 Lisa Caperelli lcaperelli@discoverylabs.com www.discoverylabs.com Discovery Labs is a biotechnology company developing its Surfactant Replacement Therapy to advance respiratory medicine and address a variety of respiratory diseases. Discovery’s technology produces a precision-engineered surfactant that is designed to mimic natural human lung surfactant. Surfaxin, Discovery’s most advanced product, has received an Approvable Letter from the US FDA for the prevention of RDS in premature infants. |
| DJA Global Pharma LLC 115 Commons Ct. Chadds Ford , PA 19317 610-558-4454 Tyrah Miles office@djaglobalpharma.com www.djaglobalpharma.com DJA Global Pharma LLC, (DJA) is a US-based global drug development and regulatory consulting company for the pharmaceutical & biotechnology industries. DJA is focused on bridging the complex areas of pharmaceutical development and commercialization of pharmaceutical products in global markets. DJA has an exceptional team of global consultants with a combined experience of well over 100 years. |
| Duska Therapeutics, Inc. Two Bala Plaza Suite 300 Bala Cynwyd, PA 19004 610-660-6690 Ms. Peggy Whearty info@duskascientific.com www.duskatherapeutic.com Duska Therapeutics, Inc. engages in the development of diagnostic and therapeutic products based on the activation or blockade of P2 receptors. It develops seven drug candidates including Vagonixen™ for the treatment of chronic obstructive pulmonary disease and chronic cough; ATPace™ for the management of cardiac arrhythmias; ATPotent™ for the treatment of male infertility and Ocuprene™ for the treatment of glaucoma. |
| Dynamis Therapeutics, Inc. 261 Old York Road Suite 427 Jenkintown, PA 19046 215-376-5290 Annette Tobia, JD, PhD ATobia@Dynamis-Therapeutics.com www.dynamis-therapeutics.com Dynamis Therapeutics was founded to capitalize on a breakthrough discovery by scientists at Fox Chase Cancer Center of a novel enzymatic pathway that leads to the production of a highly toxic sugar breakdown compound called 3-deoxyglucosone, or 3DG. Additional research confirmed that this 3DG pathway could be responsible for chronic inflammatory conditions ranging from skin wrinkling to severe diabetic complications such as retinopathy and nephropathy. |
| EKR Therapeutics, Inc. 7 East Frederick Place Cedar Knolls, NJ 07927 877-435-2524 NA postmaster@ekrtx.com www.ekrtx.com EKR Therapeutics is an emerging specialty pharmaceutical company that is focused on oncology supportive care and the commercialization of prescription products to fill unmet patient needs. |
| ElizaNor Polymer, LLC 1 Woodmeadow Lane Princeton Junction, NJ 08550-1323 609.799.2812 Dr. John Hartmann ElizaNor@aol.com ElizaNor Polymer, LLC, has developed a family of proprietary nanoparticles composed of chitosan, poly glutamic acid and hyaluronic acid(HA). The technology is flexible. Their size can be controlled (40 nm- several hundred nm) and morphology varied to suit a variety of applications. HA particle possesses remarkably low viscosity. Manufacture is in completely aqueous systems requiring no special conditions. |
| Endo Pharmaceuticals 100 Endo Boulevard Chadds Ford, PA 19317 610-558-9800 Information.General@Endo.com Information.General@Endo.com www.endo.com Endo Pharmaceuticals Inc. is a specialty pharmaceutical company with a broad portfolio of branded and generic prescription products focused on providing relief from pain. Endo is dedicated to improving the lives of patients through identifying, developing, and marketing innovative and differentiated products in pain management and related therapeutic areas. |
| ERYtech Pharma 3701 Market Street, Suite 340 Philadelphia , PA 19104 215-966-6190 Orelie Cathaud orelie.cathaud@idis.fr http://erytech.com/ ERYtech specializes in the encapsulation of therapeutic molecules and enzymes in red blood cells. ERYtech have developed and patented an innovative technology of red blood cell encapsulation of molecules and enzymes -- a major breakthrough in the fields of cancer and enzyme therapy. It is now possible to mass produce processed erythrocytes while ensuring stability, reproductibility and constant quality, whatever their initial characteristics and origin. |
| Exaeris, Inc. 403 Gordon Drive Exton, PA 19341 484-879-2272 Stephen Beckman, President info@exaeris.com www.exaeris.com Exaeris, Inc. is a specialty pharmaceutical sales and marketing company focused on improving therapeutic outcomes by delivering valued products and services to patients and physicians. A wholly owned subsidiary of Inyx, Inc., Exaeris capitalizes on Inyx’s drug delivery technologies, development platforms, and strategic global relationships to advance medical science for patients and maximize value for our partners and stakeholders. |
| FemmePharma Global Healthcare, Inc. 37 West Avenue 2nd Floor Wayne, PA 19087 610-995-0801 Joe Plevelich info@femmepharma.com www.femmepharma.com FPGHC is a specialty pharmaceutical company committed to developing safe and effective drugs that minimize or eliminate unpleasant side effects. FPGHC’s mission is to create value by developing innovative, “woman-friendly” products in identified areas of high unmet medical need and low market penetration by existing therapeutic options. |
| Fraunhofer USA Center for Molecular Biotechnology 9 Innovation Way Suite 200 Newark, DE 19711 302-369-1708 Vidadi Yusibov personnel@fraunhofer-cmb.org www.fraunhofer-cmb.org The Fraunhofer Center for Molecular Biotechnology (FhCMB) is a not-for-profit, contract research organization, developing and applying plant science and other core platform technologies for the production of valuable proteins. We have special expertise in a platform technology known as transient gene expression, which provides excellent protein yields in a short time. |
| Frontage Laboratories, Inc. 105 Great Valley Parkway Malvern, PA 19355 610-232-0100 Ron Connolly rconnolly@frontagelab.com www.frontagelab.com Frontage Laboratories is a leading pharmaceutical development company delivering high-quality research services to support pharmaceutical discovery, development and commercialization for large and emerging companies. We assist our partners in resolving complex product development issues through our combined experience in pharmaceutical analysis, bioanalytical testing and method development, and custom synthesis of investigational compounds. Fully compliant with cGMP/GLP regulations, we offer quality services, rapid turnaround and competitive pricing. |
| Fujirebio Diagnostics, Inc. 201 Great Valley Parkway Malvern, PA 19355 610-240-3800 Jenni Magrowski magrowskij@fdi.com www.fdi.com Fujirebio Diagnostics, Inc. is a premier diagnostics company and the industry leader in biomarker assays. Fujirebio Diagnostics specializes in the clinical development, manufacturing and commercialization of in-vitro diagnostic products for the management of human disease states, with an emphasis in oncology. The company has a worldwide distribution network, which enables physicians and patients to access its diagnostic products. |
| Galleon Pharmaceuticals, Inc. Silver Lake Executive Campus 41 University Drive - Suite 400 Newtown, PA 18940 267-757-8755 Linda Souder info@galleonpharma.com www.galleonpharma.com Galleon is an early stage pharmaceutical company that is developing a new class of innovative medicines for use in a wide variety of medical specialties including pulmonology, neurology, cardiology, sleep medicine and pediatrics. |
| GeneStim LLC The Science Center 3624 Market Street Rm 503 Philadelphia, PA 19104 484-574-9633 Rob Newman rob@electrocoremedical.com GeneStim is a start-up biomedical R&D company focused on treating debilitating medical conditions by delivering non-invasive biophysical stimulation to the patient’s cells and tissues. The team is supported by a group of entrepreneurs who have successfully launched and sold other ventures. The company is headquartered in Summit, NJ, with a research lab located at the University City Science Center Port of Technology in Philadelphia. |
| Genmab, Inc. 457 N. Harrison St. Princeton, NJ 08540 609-430-2481 Lucy McNiece lmb@us.genmab.com www.genmab.com Genmab is a biotechnology company that creates and develops human antibodies for the treatment of life-threatening and debilitating diseases. Genmab has numerous products in development to treat cancer, infectious disease, rheumatoid arthritis and other inflammatory conditions, and intends to continue assembling a broad portfolio of new therapeutic products. Genmab is an international company with operations in Europe and the United States. |
| Gentis, Inc. 3624 Market St. Suite 300 Philadelphia, PA 19104 215-382-4691 David W. Anderson info@gentisinc.com www.gentisinc.com Gentis has developed and is testing a patented elastomeric material designed to augment or replace the diseased spinal nucleus. |
| GlaxoSmithKline Biopharmaceuticals 709 Swedeland Road UE4021 King of Prussia, PA 19406 610-239-3887 Anthony J Zuazo, CPA gsk.biopharm@gsk.com http://biopharm.gsk.com GSK Biopharmaceuticals is a full-service partner in the development and cGMP preparation of biopharmaceutical proteins for clinical trials and the marketplace. Our features services include the low-cost, rapid scale-up and manufacture of mammalian cell derived proteins at up to 5,000L scale and the preparation of formulated bulk products. |
| GlaxoSmithKline Consumer Healthcare One Franklin Plaza 200 North 16th Street Philadelphia, PA 19102 215-751-7209 William Koch - Consumer Healthcare Business Development william.koch@gsk.com http://us.gsk.com/medicines/consumerhealthcare.jsp A leader in the worldwide consumer healthcare market, GSK Consumer Healthcare brings oral healthcare, over-the-counter medicines and nutritional healthcare products to millions of people. |
| Gulden Ophthalmics 225 Cadwalader Ave Elkins Park, PA 19027 215 884-8105 Tom Cockley tom@guldenophthamics.com www.guldenophthalmics.com Manufacture of ophthalmic medical devices. Services include product and market research, design, rapid prototypes, patents, manufacturing, advertising, and marketing. |
| Immune Control, Inc. Four Tower Bridge 200 Barr Harbor Drive, Suite 450 West Conshohocken, PA 19428 610-941-2971 Peter Lutes plutes@immunecontrol.com www.immunecontrol.com Immune Control is founded on a novel observation—the neurotransmitter, serotonin, is essential for the replication of activated immune cells. When serotonin receptors on immune cells are blocked, the cells die. The Company is thus pursuing specific serotonin antagonists for use against lymphoproliferative cancers, autoimmune diseases, and transplant rejection. |
| Immunicon Corporation 3401 Masons Mill Road Suite 100 Huntingdon Valley, PA 19006 215-830-0777 Byron D. Hewett, President and CEO BHewett@Immunicon.com www.immunicon.com Immunicon is developing and commercializing diagnostic and research products for rare cell analysis and molecular research, with an initial focus on cancer. Our instruments and reagents are used to capture, count and characterize rare cells including circulating tumor cells in cancer patients or circulating endothelial cells, which are elevated in a variety of diseases. |
| Immunotope, Inc. The Pennsylvania Biotechnology Center 3805 Old Easton Road Doylestown, PA 19002 215-297-8493 Edward L. Erickson eerickson@immunotope.com www.immunotope.com Immunotope is a clinical-stage biotechnology company developing immunotherapy products for the treatment of cancer and viral infections. The Company’s lead product candidate is an immunotherapeutic vaccine for advanced stage ovarian and breast cancer. Also in development are immunotherapeutics for treatment and prevention of chronic hepatitis and HIV, and autoantibody-based tests for early-stage diagnosis of ovarian and prostate cancer. |
| Impact Biologicals, Inc. 520 Georgetown Road Wallingford, PA 19086 610-543-6320 Bernard Selling info@impactbio.com www.impactbio.com Impact Biologicals,. Inc produces recombinant proteins, cell lines and plasmids for biomedical research organizations. The company has expertise in mammalian, insect and bacterial expression systems and has purified proteins using a wide range of methods. ELISA and biochemical assays are also developed routinely. |
| InB:Biotechnologies, Inc. 9 Innovation Way Suite 100 Newark, DE 19711 302-355-0650 Jennifer Kmiec info@inb-biotechnologies.com www.inb-biotechnologies.com We are developing and commercializing a proprietary platform technology using non-genetically modified plants for the rapid production of a broad range of vaccines, therapeutic proteins and antibodies. Key advantages over conventional production systems include very large scale capacity with greatly reduced capital requirements. Our pipeline includes novel influenza, anthrax and plague vaccine candidates and therapeutic antibodies for anthrax and influenza. |
| InfraScan 3508 Market Street Suite 215 Philadelphia, PA 19104 215-387-6784 Baruch Ben Dor info@infrascanner.com www.infrascanner.com InfraScan, Inc. is a start-up medical device company that focuses on developing, commercializing and distributing of handheld diagnostic imaging devices for head injuries and stroke. InfraScan’s flagship product, the Infrascanner™, is a hand-held imaging device using near infrared (NIR) technologies for the detection of hematoma, or bleeding in the brain, in head trauma patients. |
| Integral Molecular, Inc. 3701 Market St Philadelphia, PA 19104 215-966-6061 Benjamin Doranz info@integralmolecular.com www.integralmolecular.com Integral Molecular is a biotechnology company commercializing high-value platform technologies that aid drug discovery against integral membrane proteins, including GPCRs, ion channels, and viral Envelope proteins. |
| Integromics 3711 Market St. 8th Floor Philadelphia, PA 19104 215-966-6084 Majesh Abraham majesh.abraham@integromics.com www.integromics.com Integromics provides state-of-the-art software solutions for data management and data analysis in Genomics, Proteomics and Drug Discovery. From its scientific base, Integromics offers its clients a deep and current understanding of challenges, initiatives and solutions related to Life Sciences. Integromics has formed important partnerships in industry and academia to develop technological solutions that enable clients to achieve their goals. |
| IntelliStem Orthopaedic Innovations, Inc. 3720 Spruce Street Suite 412 Philadelphia, PA 19104 215-253-3027 Simon Jawitz info@intellistem.com www.intellistem.com IntelliStem Orthopaedic Innovations, Inc.’s mission is to engineer orthopedic implants that will use our proprietary technology to eliminate long-term failure and prevent pain associated with bone loss around the device. We are committed to cutting-edge research in applying this technology to a variety of implantable devices, which will diminish health risks, reduce costs, decrease pain, and increase the quality of life for all patients. |
| Inteprod LLC 970-200 Rittenhouse Road Eagleville, PA 19403 610-650-9002 Lori Pegon inteprodinfo@inteprod.com www.inteprod.com Inteprod is a full-service supplier of comprehensive design, development, contract manufacturing, and assembly services for the medical, food safety, and pathogen detection industries. Inteprod’s deep expertise and capabilities in developing and manufacturing medical and food safety products include: handheld devices; point of care diagnostics; bedside diagnostics; LOC technology; patient monitoring; analytical instruments; minimally invasive surgical instruments; and pathogen detection diagnostics. |
| Intrexon Corporation 2650 Eisenhower Avenue Norristown, PA 19403 610-650-8734 Shannon Hodous info@intrexon.com www.intrexon.com Intrexon Corporation is a biotechnology company focused on the research and development of gene-based therapeutics for use against challenging diseases. Our comprehensive technology platform delivers highly optimized gene programs that can be tightly regulated as to their on/off state, levels of expression, and genomic positioning. The company is currently engaged in specific therapeutic initiatives targeting melanoma, glioma, cardiac hypertrophy, and Parkinson's disease. |
| Jenrin Discovery 3701 Market Street Philadelphia, PA 19104 302-379-1679 John McElroy, President & CSO j.mcelroy@jenrindiscovery.com www.jenrindiscovery.com Jenrin Discovery is a privately owned emerging pharmaceutical company focused on developing more effective and safer therapeutics for the treatment of metabolic and inflammatory disorders. The company is developing orally active small molecule analogs of currently marketed drugs. This strategy significantly reduces the time and investment required to take lead molecules into preclinical and clinical testing. |
| JM Pharmaceutical Consulting 600 Markley Street Norristown, PA 19401 845 548-5206 Jeffrey B. Medwid, PhD medwidjb@aol.com I'm a recently retired Director from Wyeth. Expertise include: API and DP Stability from IND to regulatory submissions, Chairman of API Specification Committee for 15 years, PhD Organic Chemist with 5 yrs Process Chemistry and 5 yrs Discovery Medicinal Synthetic Chemist. |
| Kensey Nash Corporation 735 Pennsylvania Drive Exton, PA 19341 484-713-2151 holly.harrity@kenseynash.com info@kenseynash.com www.kenseynash.com Kensey Nash is a medical device company providing an extensive range of products into multiple medical markets. The company has significant expertise in the design, development, manufacturing and processing of absorbable biomaterials, which has led to partnerships to commercialize technologies. Kensey Nash also sells a series of innovative endovascular products through its own direct sales force. |
| Kibow Biotech 4629 West Chester Pike Newtown Business Center Newtown Square, PA 19073 610-353-5130 Dr Rangan info@kibowbiotech.com www.kibowbiotech.com Philadelphia-based Kibow Biotech, Inc. produces cost-effective, scientifically validated products that prolong the life of kidney disease patients and also provide a better quality of life. A novel technology called “Enteric Dialysis” is used to remove uremic toxins in the bowel by probiotics. The company has also developed a range of clinically tested and scientifically formulated products to target metabolic syndrome. |
| Labrepco, Inc. 101 Witmer Road Suite 700 Horsham, PA 19044 800-521-0754 Vanessa Good sales@labrepco.com www.labrepco.com LABREPCO is a distributor of capital laboratory equipment and instrumentation to the life sciences research community., which includes the “traditional” pharmaceutical, biotechnology and government research venues as well as academic, forensic and industrial research laboratories. Our products represent a broad collection of laboratory appliances and instruments that we expertly dovetail with the specific needs of our customers. |
| Lampire Biological Laboratories, Inc. P.O. Box 270 Pipersville, PA 18947 215-795-2838 Gregory F. Krug lampire@lampire.com www.lampire.com LAMPIRE Biological Laboratories supplies antibodies, reagents, and raw materials to the pharmaceutical, diagnostic, and medical device industries, plus academic and government research institutions worldwide. Areas of expertise include antibody development, cell culture, control and reagent manufacturing, immunoassay development, veterinary sciences, and animal technology. Furthermore, LAMPIRE has earned primary vendor status with its clients through its commitment to Quality and Customer Service. |
| Lankenau Institute for Medical Research 100 Lancaster Avenue Wynnewood , PA 19096 610-645-8145 J. Todd Abrams, PhD abramsj@mlhs.org www.limr.org Lankenau Institute for Medical Research (LIMR), an independent research institute associated with Lankenau Hospital and Main Line Health. Our mission is to discover better ways to treat cancer, heart disease, and other age-associated diseases. To accelerate this concept, LIMR functions as an incubator for very early stage life science companies, has its own technology validation group, and the LIMR chemical genomics center. |
| Lazarus Therapeutics, Inc. University City Science Center 3701 Market St., 3rd Floor Philadelphia, PA 19104 215-966-6051 Edward L. Erickson eerickson@sciencecenter.org Lazarus Therapeutics, Inc., (LTI) is a neurosciences company developing and commercializing novel therapeutic products for debilitating central nervous system (CNS) conditions, with Parkinson's disease as the initial target. The Company's strategy is to create value rapidly and reach the market through: (1) the "repurposing" and/or reformulation of existing, marketed drugs; and (2) development of "orphaned" or overlooked drug candidates for CNS indications. |
| Life Sciences Computing 88 Fleming Way Princeton, NJ 08540 609-497-1773 Forough Ghahramani forough@lifesciencescomputing.com www.lifesciencescomputing.com Life Sciences Computing LLC is a consulting company that assists organizations in utilizing high performance computing to accelerate research and provides informatics services in the pharmaceutical, health, medical, and life sciences environments. Services include information technology needs assessment, solutions development and implementation, technology infrastructure design, UNIX clustering and Linux expertise, project management, and educational curriculum development for bioinformatics, health and medical informatics. |
| LifeSensors, Inc. 271 Great Valley Parkway Malvern, PA 19355 610-644-8845 x 300 Joseph Ray info@lifesensors.com www.lifesensors.com LifeSensors is a biotechnology company located 35 miles west of Philadelphia. The company markets variety of proprietary SUMOpro® protein expression and purification technologies for difficult- to-express proteins and peptides. LifeSensors has also developed Functional Protein Arrays for diagnostics and drug discovery. The company has launched number of products for ubquitin pathway research and drug discovery. |
| Locus Pharmaceuticals, Inc. Four Valley Square 512 E. Township Line Road Blue Bell, PA 19422 215-358-2000 Robert Dickey IV communications@locuspharma.com www.locuspharma.com Locus is a world leader in computational drug design. Its core technology is a fragment-based, computational approach, which it has combined with highly integrated medicinal chemistry, crystallography and biology capabilities to create a unique drug-design and development platform. Locus develops its own compounds and has entered into drug design/development collaborations with pharmaceutical partners. Development programs are focused on oral drug therapies, principally in cancer and inflammation. |
| M-Scan Inc 606 Brandywine Parkway West Chester, PA 19380 610-696-8210 Mark Rogers services.inc@m-scan.com http://www.m-scan.com M-Scan is a chemical analysis laboratory specialized in chemical testing and high-end GLP/GMP contract analytical services. We provide analytical services in the area of Life Sciences, including protein analysis, pharmaceutical analysis and bioanalysis to support the drug development program. In addition, M-Scan offers a comprehensive portfolio of environmental testing, chemical analysis testing services. |
| Medsonics US, Inc. 211 Warren Street Newark, NJ 07103 646-373-1674 Sanford A. Roth saroth@medsonics.com http://medsonics.com Our medical device is a convenient, hand-held, point- of-care, and cost-effective way to quantitatively identify, monitor and track bone fractures from inception to full healing in real time. It provides quantitative measurements and assessment of the extent and healing rate of bone fractures, and has the sensitivity to identify stress and hairline fractures. |
| Melior Discovery 860 Springdale Drive Suite 500 Exton, PA 19341 610-280-0636 ext 231 Michele Nathan Borek inquiries@meliordiscovery.com meliordiscovery.com Melior Discovery is dedicated to uncovering new therapeutic applications for partners' existing drugs. By utilizing the unique and highly efficient theraTRACE(sm)indications discovery platform, Melior can systematically study a single compound in multiple in vivo models, thereby evaluating potential utility in a variety of major therapeutic areas. |
| Merck & Co., Inc. One Merck Drive Whitehouse Station, NJ 08889 (908) 423-1000 Amy Rose amy-rose@merck.com www.merck.com Merck & Co., Inc. is a global, research-driven pharmaceutical company dedicated to putting patients first. Merck discovers, develops, manufactures, and markets vaccines and medicines to address unmet medical needs. The Company devotes extensive efforts to increase access to medicines through far-reaching programs that both donate Merck medicines and help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service. |
| MicroDysis, Inc. 1200 Florence-Columbus Rd EcoComplex Suite 212 Bordentown, NJ 08505 6096421184 Joseph Z. Huang jhuang@microdysis.com www.microdysis.com MicroDysis, Inc. is a biotechnology instrumentation company that develops, manufactures, and markets biomedical devices and equipment based upon its patented micro- and nano-fabrication platform technologies. The goal is to commercialize its Fluidic nanoArray for highly efficient, highly sensitive, easily customized, and low-cost analysis of molecular biomarkers in earlier detection of cancer and personalized medicine applications. |
| MicroMRI, Inc. 1429 Walnut Street Suite 1102 Philadelphia, PA 19102 215-564-1002 Maura Hannigan-Pierce mpierce@micromri.com www.MicroMRI.com MicroMRI specializes in commercializing highly-accurate, non-invasive biomarkers derived from next-generation imaging technology for debilitating diseases such as osteoporosis and osteoarthritis. MicroMRI then works with the medical community to validate and legitimize the biomarkers as surrogate endpoints for drug research, clinical studies and therapeutic treatment. The company’s intends to build a portfolio of imaging-based surrogate endpoints. |
| Mobinol Fuel Company 119 Hunt Club Drive Collegeville, PA 19426 484-432-9007 John J. Savarese, Ph.D.,M.D. savarej@comcast.net www.MobinolFuel.com Mobinol Fuel Company provides the equipment and technology to convert cellulosic biomass into fuel ethanol on the farm or field. "Making Green Fuel Where Green Grows" is done with Ethanoil technology and Ethanol Mobile Bio-Reactor (EMBR)units. Turn crop waste into a cash crop while also reducing dependence on petroleum fuels. |
| Modular Instruments, Inc. 26 South Church Street West Chester, PA 19382 610-738-1420 Jim Matthews Jim@mi2.com www.mi2.com Since 1984 Modular Instruments has provided pre-clinical data acquisition hardware and software. MII provides the life sciences with easy-to-use data acquisition solutions. Modular can provide everything for data acquisition: hardware, software, custom software, even SAS programming, all at very affordable prices. Please contact Jim Matthews or Dave Slater with any questions. |
| Molecular Devices 402 Boot Road Downingtown, PA 19335 800-635-5577 Mike Duvinski Mike.Duvinski@moldev.com www.MolecularDevices.com Molecular Devices Corporation is a leading supplier of high-performance bioanalytical measurement systems that accelerate and improve drug discovery and other life sciences research. Our systems and consumables enable pharmaceutical and biotechnology companies to leverage advances in genomics, proteomics and parallel chemistry by facilitating the high-throughput and cost-effective identification and evaluation of drug candidates. |
| NALGENE and NUNC Brand Products INFO PENDING 4579 Summer Hill Drive Doylestown, PA 18902 585-586-8800 Mary Cappellino info.nalgene@thermofisher.com www.nalgene.com NALGENE and NUNC Brands offer premium plastic ware for the life science laboratory. NUNC provides a full range of plates, tissue culture products and cryopreservation. NALGENE offers general laboratory products, filtration, centrifuge tubes and bottles and cryopreservation products. Count on NALGENE and NUNC for all your life science consumables. |
| NanoDrop Technologies, Inc. 3411 Silverside Rd Bancroft Building Wilmington, DE 19810 302-479-7707 Lynne Kielhorn info@nanodrop.com www.nanodrop.com NanoDrop manufactures and sells unique analytical instruments that measure absorbance or fluorescence of 1ul samples. The company's patented sample retention system uses inherent surface tension and fiber optic technology for highly accurate quantitation of nucleic acids, proteins, and a wide variety of other chromophores and fluorophores without the need for cuvettes or capillaries. |
| NanoScan Imaging, LLC 2250 Berks Road Lansdale, PA 19446 215-699-1703 Don Skerrett, CEO DSkerrett@aol.com www.nanoscanimaging.com NanoScan Imaging is managing the clinical development of N1177, a nanoparticle diagnostic pharmaceutical expected to improve x-ray computed tomography (“CT”)’s ability to diagnose and manage various forms of cancer and cardiovascular disease. NSI plans to take N1177 through proof of concept clinical studies and then sell it to a strategic partner to complete its development and commercialization. |
| Nanoselect, Inc. 15 Innovation Way (DBI) Newark , DE 19711 302-355-5987 Sal Pace pace@nanselect-sensors.com www.nanoselect.com NanoSelect is a nanotechnology company focused on the development of Carbon Nanotubes technology for specialty materials and bio-sensing applications in the Biotechnology and Medical Diagnostics industry. The company comprises a talented group of chemists, physicists and engineers dedicated to the development of MEMS and NEMS technologies in the field of life sciences. |
| NanoVec, Inc. 3701 Market Street Philadelphia, PA 19104 215-966-6000 Dr. Chad Womack cwomack@nanovec.com www.nanovec.com NanoVec, Inc. is an early stage biotechnology company developing next generation nanobiomolecular vaccines and therapeutics against infectious diseases, cancer and biothreats. |
| Neose Technologies, Inc. 102 Rock Road Horsham, PA 19044 215-315-9403 Kathryn Gregory, VP, Bus. Dev. kgregopry@neose.com www.neose.com Neose’s proprietary GlycoPEGylation technology improves the pharmacokinetic and pharmacodynamic properties of protein drugs. Candidates in development include GlycoPEG-GCSF (in collaboration with BioGeneriX AG), a phase-I completed product, for neutropenia associated with myelosuppressive chemotherapy; and GlycoPEG-FVIIa (under a license to Novo Nordisk) for the treatment of bleeding episodes and prevention of bleeding during surgery or invasive procedures in patients with congenital hemophilia with inhibitors to coagulation factors. |
| Neuro Diagnsotic Devices 3701 Market Street Philadelphia, PA 19104 215-966-6104 Fred Fritz ffritz@neurodx.com www.neurodx.com NeuroDx is a medical device company addressing important unmet needs in the neurosurgical market. Our lead product, ShuntCheck™, is FDA cleared and addresses the $200 million cerebrospinal fluid (CSF) flow monitoring market. ShuntCheck™ will be launched into the US market in Q4’07 and will be the only product capable of directly and non-invasively assessing CSF shunt function in hydrocephalus patients. |
| Neuromed Pharmaceuticals, Inc. Six Tower Bridge, Suite 440 181 Washington Street Conshohocken, PA 19428 484-533-6900 Julie Jang info@neuromed.com www.neuromed.com Neuromed is a privately held biopharmaceutical company developing a new generation of chronic pain drugs with additional programs in hypertension and epilepsy. The company’s drug development programs are designed around validated clinical targets associated with large unmet markets. Neuromed is the first company to advance an oral N-type calcium channel blocker into human clinical trials. |
| Neuronetics, Inc. One Great Valley Parkway Suite 2 Malvern, PA 19355 610-640-4202 Jennifer Bullock jbullock@neuronetics.com www.neuronetics.com Neuronetics is a medical device company developing a non-invasive therapy known as the NeuroStar TMS Therapy™ system for the treatment of chronic psychiatric and neurologic disorders. TMS (Transcranial Magnetic Stimulation) Therapy involves the application of high intensity magnetic field pulses to non-invasively stimulate the brain. The Company’s lead opportunity is major depression – the single largest segment of mental health. |
| Neuronyx, Inc. 1 Great Valley Parkway Suite 20 Malvern, PA 19355 610-240-4150 Mary K. Luke info@neuronyx.com www.neuronyx.com Neuronyx is developing an allogeneic human adult bone marrow-derived somatic cell product (NX-CP105) for certain diseases resulting from ischemic injury such as myocardial infarction, stroke and dermal wounds. |
| Nexis Development, LLC 400 N. Buckstown Road Suite 2C Langhorne, PA 19047 215-741-0500 Pier Cipriani piercipriani@verizon.net www.nexisdev.com Nexis currently develops bacterial biofilm technologies that may first be used by pharmaceutical companies to dramatically increase efficiency and lower costs of the drug discovery process. The technologies involve the use of bacterial quorum sensing (cell-to-cell communication) used in conjunction with microlithographic arrays (microchips). |
| NexusPharma Inc. 253-13 Summit Square Center Langhorne, PA 19047 732-274-0010 Lutz Weber info@nexuspharm.com www.nexuspharm.com NexusPharma is developing novel drug candidates to advance cancer treatment through non-cytotoxic mechanism-based approaches. The small molecule candidates target selected cancer-promoting protein-protein interactions and inhibit critical cancer signaling networks. NexusPharma leverages its new technologies for the design and development of small molecule protein-protein interaction inhibitors with the unique know-how, cell and systems biology expertise, and insight into the complex networks of cancer-related protein interactions of the Fox Chase Cancer Center. |
| Nitric BioTherapeutics, Inc. 2 Canal's End Road Suite 201-A Bristol, PA 19007 866-957-6200 NA info@nitricbio.com www.nitricbio.com NitricBio was created to develop and commercialize medical applications of topical nitric oxide gas. Nitric oxide has both direct and regulatory actions with known anti-infective and anti-inflammatory properties. Among the company's first initiatives is the treatment of chronic wounds, a major health care issue. |
| NovaPedix 1735 Market Street Philadelphia, PA 19103 215-299-6528 Dr. Joseph Zindulis jzindulis@novapedix.com www.novapedix.com NovaPedix is developing highly purified alginates for several surgical orthopedic applications. These include the use of biopolymers in resorbable bone scaffolding and load-bearing, resorbable internal bone fixation. |
| Novartis 180 Park Ave Florham Park, NJ 07932 609-610-0388 Swadesh Sharma swadesh76@yahoo.com www.novartis.com Leading Pharmaceutical company winning for the patient. |
| Novasep Process 23 Creek Circle Boothwyn, PA 19061 610-494-0447 Rache Deluca rachel.deluca@novasep.com www.novasep.com Novasep Process is leader in delivering innovative purification solutions for life sciences applications. Novasep Process solves purification challenges for the Pharmaceutical, Biopharmaceutical and Industrial Biotech markets. Novasep Process is part of the Groupe Novasep who is a technology-oriented company offering a large portfolio of innovative and cost effective syntheses and processes to produce molecules. |
| Novavax, Inc. 508 Lapp Road Malvern, PA 19355 484-913-1204 Robert Lee RLee@Novavax.com www.Novavax.com Novavax, Inc. is committed to leading the global fight against infectious disease by creating novel, highly potent vaccines that are safer and more effective than current preventive options. In addition, Novavax has pharmaceutical development capabilities which include micellar nanoparticle (MNP) technology, an enabling drug delivery platform. MNP technology is the basis for the development of its first FDA-approved product, Estrasorb®. |
| Novo Nordisk, Inc. 100 College Road West Princeton, NJ 08540 609-987-5800 Stephen McGill stnc@nvonrdsk.com www.novonordisk-us.com Novo Nordisk is the world's leading diabetes care company and the only company that provides a complete portfolio of insulin analog treatments and insulin delivery devices that respond to each stage of the diabetes life cycle. In addition, Novo Nordisk has a leading position in hemostasis management, growth hormone therapy and hormone therapy for women. |
| Nucleonics, Inc. 702 Electronic Drive Horsham, PA 19044 267-518-0100 Barbara Guido bguido@nucleonicsinc.com www.nucleonicsinc.com Nucleonics is developing novel therapeutics for infectious diseases, cancer and inflammatory conditions based on proprietary gene silencing technology known as expressed RNA interference. |
| NuPathe, Inc. 375 E. Elm Street Suite 110 Conshohocken, PA 19428 484-567-0130 Pola Milan info@nupathe.com www.nupathe.com NuPathe, Inc. is a specialty pharmaceutical company specializing in the development of innovative therapeutic products in the field of neuroscience. Our mission is to identify opportunities for therapeutic advances in the treatment of neurologic and psychiatric disorders and to license and develop compounds and technologies that meet these needs. NuPathe management has a proven track record in identification and development of novel therapeutic approaches. |
| Open Biosystems, Inc. 34 Sebastian Drive Newark, DE 19711 302-650-0100 Bill Morrison info@openbiosystems.com www.openbiosystems.com Open Biosystems offers products that span Genomics, RNAi and Antibodies. We offer several full-length cDNA and ORF collections, including the Mammalian Gene Collection (MGC). Our collaborations with Cold Spring Harbor Laboratory, MIT and Harvard have led the way in shRNA libraries. Open Biosystems is also the premier provider of antigen and antibody services, based on unique Antigen Profiler design software. |
| Orthovita, Inc. 77 Great Valley Parkway Malvern, PA 19355 610-640-1775 Antony Koblish, President & CEO akoblish@orthovita.com www.orthovita.com Orthovita is a spine and orthopedic biosurgery company with proprietary biomaterials and biologic technologies for the development and commercialization of synthetic, biologically active, tissue engineering products. Orthovita develops and markets synthetic-based biomaterials products for use in spine surgery, the repair of fractures and a broad range of clinical needs in the trauma, joint reconstruction, revision and extremities markets. |
| Othera Pharamceuticals, Inc. 730 Springdale Drive Exton, PA 19341 484-879-2800 Tina Paquin paquin@othera.com www.othera.com We are a specialty pharmaceutical company, focused on the design, development and commercialization of proprietary small molecule drugs for ophthalmic and other high-value indications based on a novel mechanism of action. Our primary interest in ophthalmics is to develop novel topical eye drop products that target age-related indications representing some of the biggest unmet needs in ophthalmology. |
| OTOVATION 1001 W. Ninth Ave. Suite A King of Prussia, PA 19406 610-768-9300 Mark Exley info@otovation.com www.otovation.com Otovation develops and markets innovative solutions for hearing diagnostics. Founded in 2003, the company offers advanced portable devices used by physicians, audiologists, schools, researchers and occupational health testing markets. |
| Parsortix, Inc. 1835 Market Street Suite 1100 Philadelphia, PA 19103 215-972-1671 Larissa Milne larissa.milne@parsortix.com Microfluidic cell sorting for use in subsequent biomedical applications. Core technology involves a "cartridge" roughly the size of a microscope slide to isolate rare cells from a mixed cell population, such as that of whole blood. Applications in diagnostics, therapeutics, research. |
| Particle Sciences Inc. 3894 Courtney Street Courtney 1, Suite 180 Bethlehem, PA 18017 610-861-4701 Maureen Cochran mcochran@particlesciences.com www.particlesciences.com Particle Sciences is an integrated provider of drug development services. Our focus is on emulsions, gels, particulates and drug/device combination products with specialized capabilities in topical and mucosal delivery. PSI offers a full range of formulation, analytic, and GLP/GMP manufacturing services – including sterile products. The company was founded in 1991 and is headquartered in Bethlehem, Pennsylvania. For more information on Particle Sciences, visit www.particlesciences.com. |
| Patients' & Consumers' Pharma 2333 West Main Street Suite 202 Lansdale, PA 19446 215-361-8030 Joseph D'Silva joe.dsilva@pandcpharma.com Patients’ & Consumers’ Pharma's mission is to be the premier company to make available customized medication therapies. We research and develop technology that fulfills our vision of “An individual patient – A unique need – A distinctive product solution.” We are an emerging start-up organization in early phase development and seek funding opportunities. |
| PBL InterferonSource 131 Ethe Rd West Suite 6 Piscataway, NJ 08854 173-277-79123 Jaleel Shujath info@interferonsource.com www.interferonsource.com PBL InterferonSource, a division of Pestka Biomedical Laboratories, is the world’s largest distributor of interferons and related products to the life sciences research market. Founded in 1990 by Dr. Sidney Pestka, PBL aims to provide the biomedical researcher with high quality interferon products and facilitate the advancement of research. |
| Penn Center for Molecular Discovery 1024 Vagelos Research Laboratories 3340 Smith Walk Philadelphia, PA 19104 215-573-5702 Scott Diamond, Ph.D. sld@seas.upenn.edu www.seas.upenn.edu/~pcmd/ The PCMD is a multi-disciplinary center that screens small molecules from around the world in search of new, potentially useful, biologically effective agents. |
| Pharmabridge, Inc. Pennsylvania Biotechnology Center of Bucks County 3805 Old Easton Road Doylestown, PA 18902 215-589-6350 Dr. Michael Xu michaelxu@pharmabridgegroup.com www.pharmabridgegroup.com Pharmabridge, Inc. provides chemistry support service for pharmaceutical and biotechnology companies. Our services range from drug discovery services, custom synthesis and catalog chemicals. |
| PhenoTech, Inc. 3624 Market Street 5E Philadelphia, PA 19104 610-761-7311 Guy Maestre maestre@phenotech.com www.phenotech.com PhenoTech is a privately held biotechnology company pioneering the discovery, development and commercialization of a highly innovative class of reagents for diagnostic use in blood banks. These products will improve blood transfusions by allowing physicians to match better the donors and patients blood types, thereby reducing potential negative transfusion reactions. Their use should also significantly reduce blood typing costs. |
| Polysciences Inc. 400 Valley Road Warrington, PA 18976 215-343-6484 Robert Gleim-VP New Business Development info@polysciences.com www.polysciences.com Polysciences Inc. is a privately held specialty chemical company that offers a range of product service including custom synthesis, contract manufacturing and packaging of biomedical products and intermediates. |
| Prescient Medical, Inc. 2005 South Easton Road Suite 204 Doylestown, PA 18901 215-933-1150 N/A info@prescientmedical.com www.prescientmedical.com Prescient Medical, Inc. was founded to commercialize pioneering products for the prevention of heart attacks caused by vulnerable plaque. |
| Prism Pharmaceuticals, Inc. 1150 First Ave. Suite 1050 King of Prussia, PA 19406 610-265-7710 Stan Musial, CFO smusial@prismpharma.com www.prismpharma.com Prism Pharmaceuticals Inc. is a specialty pharmaceutical company that commercializes branded prescription products for acute care indications. The Company is led by Dr. Warren Cooper, a former drug development and general management executive at Merck Research Laboratories, AstraMerck and AstraZeneca. Prism is establishing a robust product portfolio through aggressive licensing and acquisition of commercially branded products and compounds in late-stage development. |
| Progenra, Inc. Great Valley Corpoprate Center 271A Great Valley Parkway Malvern, PA 19355 610-644-6974 Michael R Mattern mattern@progenra.com www.progenra.com Progenra Inc. is a biotechnology company committed to drug discovery utilizing the ubiquitin and ubiquitin-like protein pathways. Through its platform for high-throughput screening against novel drug targets in these pathways, Progenra’s goal is to develop medicines to treat cancer, muscle wasting, Parkinson’s, and other diseases. Progenra is currently expanding its discovery platform to include every viable target in these pathways. |
| Promedior, Inc. 5 Great Valley Parkway Suite 300 Malvern, PA 19355 610-560-1435 Timothy J. Pelura, Ph.D. tpelura@promedior.com www.promedior.com Promedior, Inc. is a product-focused biopharmaceutical company developing novel therapeutics for the treatment of fibrotic disorders and diseases. Promedior has license to novel biology and is developing innovative new compounds and therapies based on that biology. With leadership and advisors on the cutting edge of fibrosis research, Promedior is positioned to be a leader in the development of new therapies for fibrotic disorders and diseases. |
| Protalex, Inc. 145 Union Square Drive New Hope, PA 18938 215-862-9720 Marc L. Rose information@protalex.com www.protalex.com Protalex, Inc. is a biotechnology company developing a novel, new class of drugs for the treatment of various autoimmune disorders. |
| Protez Pharmaceuticals 30 Spring Mill Drive Malvern, PA 19355 610-695-0200 Karen Jurasits jurasits@protez.com www.protez.com Discovers and develops hospital antibiotics for difficult-to-treat infections |
| PuriCore, Inc. 508 Lapp Road Malvern, PA 19355 484-321-2700 Kelli Johnson kjohnson@puricore.com www.puricore.com A life sciences company developing and commercializing technology that mimics the human body’s production of its natural anti-microbial, hypochlorous acid. Hypochlorous acid is highly effective at killing pathogens, yet is safe and environmentally friendly. |
| Real Time X, Corp. 1510 Cecil B. Moore Avenue Suite 301 Philadelphia, PA 19121 267-979-9250 Daniel Uzbelger Feldman uzbelger@realtimedentistry.com www.realtimedentistry.com RTXC’s mission is to revolutionize dentistry by delivering innovative, top-quality, real-time imaging solutions that will improve professionals’ ability to diagnose disease, “see” their procedures during performance, save working time, reduce procedural errors and provide increased safety and better care to their patients. |
| Redpoint Bio Corporation 2005 Eastpark Blvd. Cranbury, NJ 08512 609-860-1500 Ray Salemme bhoover@redpointbio.com www.redpointbio.com Redpoint Bio is a development-stage biotech company using advanced technology to discover and develop novel taste enhancers and aversive taste blockers for the pharmaceutical, food and beverage industries. We are developing more palatable formulations of medicines that offer improved acceptability and compliance, or allow novel routes of administration through absorption in the mouth. |
| Renaissance Scientific, LLC 309 Parklawn Court Lancaster, PA 17601 717-575-0115 Sandra Urdaneta Hartmann, M.D., Ph.D. rensci@hotmail.com Scientists of our early-stage company discovered and patented the novel use of sodium dodecyl sulfate (SDS) as the active ingredient in personal care products (e.g., gels/lubricants, condoms) for prevention of sexual transmission of human immunodeficiency virus type 1 (HIV-1), herpes simplex virus type 2 (HSV-2) and human papillomaviruses (HPV). Other novel broad-spectrum microbicidal applications of SDS are in the pipeline. |
| Rockland Immunochemicals, Inc. P.O. Box 326 Gilbertsville, PA 19525 800-656-7625 Tabitha A. Patrick sales@rockland-inc.com www.rockland-inc.com Rockland Immunochemicals is a global biotechnology company manufacturing leading-edge research tools and cGMP grade proteins for basic, applied and clinical research in functional genomics, gene therapy and drug discovery markets. Rockland operates outside of Philadelphia, Pennsylvania, USA. European and Asian markets are supported through a highly specialized network of key distributors. |
| Russell Biotech, Inc. 634 Meadwobrook Drive Huntingdon Valley, PA 19006 215-914-1276 Thomas Russell trussell@russellbiotech.com www.russellbiotech.com Russell Biotech provides innovative solutions for biological separations based on proprietary technology. Applications include separation of cells, proteins and nucleic acids. Products are being developed for research, diagnostic and therapeutic markets. |
| Sbarro Health Research Organization Temple University 1900 North 12th Street Philadelphia, PA 19122-6099 215-204-9520 Ilene Raymond Rush Info@shro.org www.shro.org The Sbarro Health Research Organization (SHRO) in Philadelphia is a nonprofit charity that finances and promotes the work of established researchers and young scientists in medicine, molecular biology, genetics, physics, chemistry and biomathematics. SHRO funds the Sbarro Institute for Cancer Research and Molecular Medicine located at Temple University and a laboratory at the University of Siena in Italy. |
| Schering-Plough Corporation 2000 Galloping Hill Road Kenilworth, NJ 07033 908-298-6720 Michael J. DuBois michael.dubois@spcorp.com www.schering-plough.com Schering-Plough is a global, science-based health care company with leading prescription, consumer and animal health products. Through internal research and collaborations with partners, Schering-Plough discovers, develops, manufactures and markets advanced drug therapies to meet important medical needs. Schering-Plough's vision is to earn the trust of the physicians, patients and customers served by its approximately 33,500 people around the world. |
| Scitek Ventures 899 Denton Hollow Road West Chester, PA 19382 610-368-8510 Jim Serum jserum@scitekventures.com www.scitekventures.com SciTek Ventures is a consulting firm focused on helping early stage life sciences & technology companies define their business strategy, raise capital, and create value from their technology. We act as a catalyst, utilizing our experience in science, technology and business to challenge, stimulate and focus early stage companies to achieve their goals. |
| Scott Medical Products 6141 Easton Road P.O. Box 310 Plumsteadville, PA 18949-0310 215-766-7407 David J Gibboni, PhD, Business Devel Mgr dgibboni@scottgas.com www.scottgas.com Scott Medical Products provides pure gases and mixtures as Class I, II, and III device gases, therapeutic gases, and active pharmaceutical ingredients for calibration of medical devices in anesthesia monitoring, blood gas monitoring and pulmonary testing. We are an exclusive supplier for non-gas fluorinating reagents and fluorinated compounds for pharmaceutical applications. We are FDA-registered and ISO 13485 certified. |
| Secant Pharma 907 Edgewood Lane Langhorne, PA 19053 215-741-1165 Dale M. Lombardi dlombardi@secantpharma.com www.secantpharma.com Secant Pharma is a U.S.-based privately held specialty pharmaceutical company that operates internationally and is devoted to the development and commercialization of innovative, differentiated, value-generating therapeutics for market segments with unmet medical needs. The primary focus of the company at this time is to fully capitalize on the intellectual property that it owns. |
| Sensory Arts & Science 1001 W. Ninth Ave. Suite A King of Prussia, PA 19406 610-768-9300 Dave Davis info@sensoryarts.com www.sensoryarts.com Sensory Arts & Science is a biomedical device and technology company, developing innovative methods, devices, and enabling technologies that address some of the most critical diseases and conditions that affect human sensory function. We apply innovative thinking and advanced technology to aid in the prevention, early detection, better measurement, and rehabilitation of certain broad-based population health issues, diseases and conditions. |
| Sepax Technologies, Inc. Delaware Technology Park 5-100 Innovation Way Newark, DE 19711 302-366-1101 Chris Huang, Ph.D. info@sepax-tech.com www.sepax-tech.com Sepax Technologies, Inc. develops and manufactures products in the area of chemical and biological separations, biosurfaces and proteomics. The Sepax product portfolio includes a wide range of high resolution, high efficiency liquid chromatography instruments, columns, resins, and novel capillary coatings for DNA sequencing and protein separation. |
| Shire Pharmaceuticals 725 Chesterbrook Boulevard Wayne, PA 19087 484-595-8110 Barbara Deptula businessdevelopment@shire.com www.shire.com Shire is a leading specialty pharmaceutical company that focuses on meeting the needs of the specialist physician. Shire centers its business ADHD, human genetic therapies, gastrointestinal (GI), and renal diseases. Shire has operations in the world’s key pharmaceutical markets including the US, Europe, Canada and South America. |
| Simmons Consulting 19 Stirrup Run Newark, DE 19711 302-379-1876 Kirk Simmons SimmonsConsulting@gmail.com http://www.linkedin.com/in/kirksimmons Simmons Consulting provides consulting services in the area of cheminformatics, screening library design, design of experiments (DOE), predictive modeling and analysis of high-throughput experimental results. Extensive experience in organic chemistry, lead optimization strategies, and physical property predictions of small organics (logS, logVp and pKa). |
| Skanska USA Building, Inc. 516 East Township Line Road Suite 100 Blue Bell, PA 19422 267-470-1000 Ron Jones ron.jones@skanskausa.com www.skanskausa.com Skanska is a leader in providing construction services to clients in the pharmaceutical and biotechnology manufacturing/process industries. We have the capabilities to construct, renovate and expand facilities from 1,000 square feet to more than 300,000 square feet. We also specialize in handling projects in Puerto Rico for many of our clients, with whom we’ve developed long-term relationships – making us a leader in repeat business. |
| SMART Biosciences 3701 Market Street Philadelphia, PA 19104 215-966-6072 J. E. Foley jefoley@smartbiosciences.com www.smartbiosciences.com SMART Biosciences, Inc., a Columbia University spin-off biotechnology company, aims to develop novel small-molecule therapeutics for the treatment of major age-associated human diseases such as Alzheimer’s disease (AD) and cancer. SMART believes that its intellectual property, validated targets, and scientific rationale for future compound discovery provide a competitive opportunity to exploit the commercial potential of these unsatisfied markets. |
| Soligenix, Inc. 29 Emmons Drive Suite C-10 Princeton, New Jersey 08650 609-538-8200 Annu Mangat info@soligenix.com www.soligenix.com Soligenix, Inc. is a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. Soligenix's lead product, orBec® (oral beclomethasone dipropionate or BDP), is a potent, locally acting corticosteroid being developed for the treatment of acute gastrointestinal Graft-versus-Host disease (GI GVHD), a common and potentially life-threatening complication of allogeneic hematopoietic cell transplantation. |
| Sopherion Therapeutics 104 Carnegie Center Suite 200 Princeton, NJ 08540 609-986-2021 NA info@sopherion.com www.sopherion.com Sopherion Therapeutics, Inc. is a privately held biopharmaceutical company headquartered in Princeton, New Jersey and maintains preclinical R&D in New Haven, Connecticut and an operating subsidiary, Sopherion Therapeutics Canada, in Toronto, Canada. The Company is focused on developing oncology and oncology-related therapies and is leveraging its Minicell Peptide Display™ screening technologies to identify additional therapies for cancer and related areas. |
| SSPCC, Inc. 21 Pin Oaks Drive Suite 101 Phoenixville, PA 19460 610-933-9689 Caroline Bell cpbell@sspcc.com sspcc.com Consultant, Preclinical Development and IND Strategy. 25+ years pharmaceutical R&D. Toxicology and Safety Pharmacology - CRO Management (protocol, in-life, report, regulatory summary documents), facility audit, design/implementation of in-house capability. Risk/safety profiles assessment, IND/NDA submissions. State-of-the-art Safety Pharmacology technologies, GLP, Investigative studies Phase II-IV, preclinical toxicological issues, regulatory reports, executive operations management. Board of Directors Safety Pharmacology Society. Full resume www.sspcc.com |
| Stan Bumble, PH.D. 8922 Krewstown Rd., 112 Philadelphia, PA 19115 215-671-0409 Stan Bumble, Ph. D. stan2@excite.com Synthetic Biology, Systems Biology, New Energy Sources, Metabolic Engineering, Genetic, Protein and Metabolic Networks, Alternate Biochemical Pathways for Microbial Synthesis, Robust Self-Assembly, Evolution of Biological Networks, Biological Process Network Synthesis and Analysis, Chaos Theory, Critical Areas Between Chaos and Order, Emergence and Expression in Biological Systems, Improved Databases for the Combinatorial Computer Generation of Candidate Drug Molecules and Their Discovery, Program Design for Smarter Lead Discovery. |
| Strategic Diagnostics, Inc. 111 Pencader Drive Newark, DE 19702 302-456-6789 David Schlecker dschlecker@sdix.com www.sdix.com Strategic Diagnostics Inc., headquartered in Newark, DE, is a biotechnology company dedicated to bringing innovative solutions to the production of custom and catalogue antibodies as well analytical testing problems. SDI is a leading developer of test kits for waste site assessment, water quality, food pathogens and transgenic crop seed production. SDI pioneered the production of Antibodies by developing Genomic Antibodies. |
| Study Advantage 7 Great Valley Parkway Malvern, PA 19355 215-885-9500 Dan Falk support@studyadvantage.com http://studyadvantage.com Study Advantage offers a complete automated solution for the conduct of animal studies, including design, data acquisition, and analysis of results. We help you accelerate the drug discovery process by making your animal studies easier, more accurate, and less costly. |
| TDM Pharmaceutical Research, LLC 100 Biddle Ave. Suite 202 Newark, DE 19702 302-832-1008 Dana A Janssen Info@TDMRXResearch.com www.TDMRXResearch.com TDM Pharmaceutical Research, LLC is a well established and highly productive contract research organization (CRO), offering a variety of bioanalytical discovery, development, and clinical support for the global pharmaceutical industry. TDM is a full service GLP and GCP compliant laboratory with CLIA certification. We specialize in the areas of bioanalysis, method development, and pharmacokinetics, providing a customized approach to each client and their projects. We focus on your priorities, while maintaining rapid data turn around, accuracy, and quality that are critical to your business. |
| Tengion, Inc. 2900 Potshop Lane Suite 100 East Norriton, PA 19403 610-292-8364 Gary Sender, CFO info@tengion.com www.tengion.com Tengion, a clinical stage company founded in 2003, is developing new human tissues and organs derived from a patient's own cells. Tengion's patented technology harnesses the body's ability to regenerate, which has the potential to allow adults and children with organ failure to have functioning organs built from their own tissues. This would enable them to lead healthier lives without the need for donor transplants. |
| TetraLogic Pharmaceuticals Corporation 343 Phoenixville Pike Malvern, PA 19355 610-889-9900 Amy Greene agreene@tetralogicpharma.com www.tetralogicpharma.com TetraLogic Pharmaceuticals specializes in oncology therapeutics. The Company’s lead program is developing a novel class of small molecules that enable cancer cells to die by apoptosis, or programmed cell death. TetraLogic has raised about $50 million since 2004 and its investors include PA Early Stage, Quaker BioVentures, Healthcare Ventures, Latterell Venture Partners, the Vertical Group and Amgen Ventures. |
| The Business/Technology Interface, LLC 21 Tenby Chase Voorhees, NJ 08043 856-753-7650 Richard S. Woodward rswoodward@net-gate.com The Business/Technology Interface, LLC provides business strategy, business development and technical operations support to early-stage companies in the pharma, biotech and specialty chemicals fields. These services have been characterized as a "COO for hire." |
| The ORION Group 3809 Violet Dr Philadelphia, PA 19154 267.825.1287 Matthew J. O'Brien, Ph.D. mobrien12@aol.com Experienced in quality and regulatory matters with almost 40 years experience in these areas (>30 NDAs and 120 INDs). Significant experience with stability protocols, specifications and methods validation. Also CTD, laboratory management and product development. |
| Thomas Medical Products, Inc. 65 Great Valley Parkway Malvern, PA 19355 610-296-3000 Mark Kesti mkesti@thomas-medical.com www.thomas-medical.com Thomas Medical Products, Inc. focuses on vascular access and vascular device delivery medical devices for the interventional cardiology, interventional radiology and cardiac rhythm markets. As an OEM, the company supports all aspects of medical device development and finished device manufacturing. These resources include Research & Development, Regulatory Affairs, Quality Assurance, Manufacturing Engineering, clean room manufacturing and packaging and product sterilization. |
| Topaz Pharmaceuticals LLC 130 Greenwwod Ave. Jenkintown, PA 19046 215 990 5145 Nick Spring nick_spring@topazpharma.com www.topazpharma.com The mission of Topaz Pharmaceuticals LLC is to provide the field of pediatrics with innovative products that will facilitate the treatment of common pediatric diseases and conditions, especially those that occur in children from 0 -13 years of age. The initial focus of Topaz Pharmaceuticals LLC will be on head lice control products. |
| Toxikon 1255 Marigold Street North Brunswick, NJ 08902 716-566-8181 Charudutt Shah charudutt.shah@toxikon.com www.toxikon.com Toxikon is an industry leading global contract research organization that has been serving the life science community for over 30 years. Our facilities in US and Europe provide FDA/ICH/OECD safety testing services for the medical device and biotechnology industries. We specialize in biocompatibility studies, sterilization, microbiology, extractables and leachable studies, PK/TK, ADME, in-vivo toxicology, IND enabling studies and bio-analytical services with GxP standards. |
| Vector BioLabs 3701 MARKET ST, Ste 434 Philadelphia, PA 19104 215-966-6045 Ken Guo, PhD info@vectorbiolabs.com www.vectorbiolabs.com Vector Biolabs is a biotechnology company focusing on the development of gene delivery technology for the life science research community. |
| VWR International 1310 Goshen Parkway West Chester, PA 19380 610-431-1700 Erika Broadwater erika_broadwater@vwr.com www.vwrjobs.com VWR International is a leader in the global research laboratory industry with worldwide sales in excess of $3 billion US dollars. VWR's business is highly diversified across products and services, geographic regions and customer segments. The company offers products from a wide range of manufacturers, to a large number of customers primarily in North America, Europe and other locations. |
| Wyeth Pharmaceuticals 500 Arcola Rd. Collegeville, PA 19426 484-865-5000 Patrick Plues pluesp@wyeth.com www.wyeth.com Wyeth is a global leader in prescription pharmaceuticals, non-prescription consumer health products, and pharmaceuticals for animal health. Wyeth's product portfolio includes innovative treatments across a range of therapeutic areas. Wyeth's resources include 50,000 employees, manufacturing facilities on four continents, and a technology base encompassing small molecules, biopharmaceuticals, genetic engineering that will provide the next wave of innovative therapies and vaccines. |
| Yaupon Therapeutics, Inc. 259 Radnor Chester Road Suite 210 Radnor, PA 19087 610-975-9290 Robert Alonso robert@yaupontherapeutics.com www.yaupontherapeutics.com Yaupon Therapeutics is a privately held specialty pharmaceutical company that develops small molecule pharmaceuticals licensed from under-served academic laboratories using an intensely capital-efficient business model. The company has four products in development, with one compound in pivotal studies, one compound in phase 2 and additional compounds that will enter the clinic in 2007. |
| YM BioSciences, Inc. 701 Lee Road Suite 200 Wayne, PA 19087 610-560-0600 Gary Floyd ir@ymbiosciences.com www.ymbiosciences.com YM BioSciences is an oncology company that identifies, develops and commercializes differentiated products for patients worldwide. Late-stage products include nimotuzumab, a humanized monoclonal antibody that targets the epidermal growth factor receptor (EGFR); and AeroLEF™, a unique, inhaled-delivery composition of free and liposome-encapsulated fentanyl, in development for the treatment of moderate to severe pain, including cancer pain. |